nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.131	0.16	CbGbCtD
Loratadine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0915	0.112	CbGbCtD
Loratadine—CYP2C8—Progesterone—uterine cancer	0.0869	0.106	CbGbCtD
Loratadine—CYP2C19—Progesterone—uterine cancer	0.0729	0.089	CbGbCtD
Loratadine—CYP2C9—Progesterone—uterine cancer	0.0606	0.074	CbGbCtD
Loratadine—ABCB1—Progesterone—uterine cancer	0.0588	0.0718	CbGbCtD
Loratadine—CYP2D6—Progesterone—uterine cancer	0.0554	0.0677	CbGbCtD
Loratadine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0532	0.065	CbGbCtD
Loratadine—ABCB1—Dactinomycin—uterine cancer	0.0466	0.057	CbGbCtD
Loratadine—CYP2C8—Etoposide—uterine cancer	0.0389	0.0475	CbGbCtD
Loratadine—CYP3A4—Progesterone—uterine cancer	0.0352	0.043	CbGbCtD
Loratadine—ABCB1—Etoposide—uterine cancer	0.0263	0.0321	CbGbCtD
Loratadine—ABCB1—Doxorubicin—uterine cancer	0.018	0.0219	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—uterine cancer	0.0169	0.0207	CbGbCtD
Loratadine—CYP3A4—Etoposide—uterine cancer	0.0158	0.0193	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—uterine cancer	0.0108	0.0131	CbGbCtD
Loratadine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.000962	0.00586	CcSEcCtD
Loratadine—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00096	0.00585	CcSEcCtD
Loratadine—Palpitations—Progesterone—uterine cancer	0.000956	0.00583	CcSEcCtD
Loratadine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000952	0.0058	CcSEcCtD
Loratadine—Loss of consciousness—Progesterone—uterine cancer	0.00095	0.0058	CcSEcCtD
Loratadine—Cough—Progesterone—uterine cancer	0.000944	0.00575	CcSEcCtD
Loratadine—Hypertension—Progesterone—uterine cancer	0.000934	0.00569	CcSEcCtD
Loratadine—Chest pain—Progesterone—uterine cancer	0.000921	0.00561	CcSEcCtD
Loratadine—Myalgia—Progesterone—uterine cancer	0.000921	0.00561	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000914	0.00558	CcSEcCtD
Loratadine—Blister—Doxorubicin—uterine cancer	0.000911	0.00555	CcSEcCtD
Loratadine—Discomfort—Progesterone—uterine cancer	0.00091	0.00555	CcSEcCtD
Loratadine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000909	0.00554	CcSEcCtD
Loratadine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000901	0.00549	CcSEcCtD
Loratadine—Dry mouth—Progesterone—uterine cancer	0.0009	0.00549	CcSEcCtD
Loratadine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000895	0.00546	CcSEcCtD
Loratadine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000884	0.00539	CcSEcCtD
Loratadine—Anaphylactic shock—Progesterone—uterine cancer	0.000883	0.00538	CcSEcCtD
Loratadine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000879	0.00536	CcSEcCtD
Loratadine—Pharyngitis—Dactinomycin—uterine cancer	0.000871	0.00531	CcSEcCtD
Loratadine—Shock—Progesterone—uterine cancer	0.000868	0.0053	CcSEcCtD
Loratadine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000866	0.00528	CcSEcCtD
Loratadine—Nervous system disorder—Progesterone—uterine cancer	0.000866	0.00528	CcSEcCtD
Loratadine—Tachycardia—Progesterone—uterine cancer	0.000861	0.00525	CcSEcCtD
Loratadine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000861	0.00525	CcSEcCtD
Loratadine—Skin disorder—Progesterone—uterine cancer	0.000857	0.00523	CcSEcCtD
Loratadine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000834	0.00509	CcSEcCtD
Loratadine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000834	0.00509	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000829	0.00505	CcSEcCtD
Loratadine—Hypotension—Progesterone—uterine cancer	0.000825	0.00503	CcSEcCtD
Loratadine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000824	0.00503	CcSEcCtD
Loratadine—KCNH2—myometrium—uterine cancer	0.000822	0.0485	CbGeAlD
Loratadine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000816	0.00498	CcSEcCtD
Loratadine—Cardiovascular disorder—Epirubicin—uterine cancer	0.000807	0.00492	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000804	0.0049	CcSEcCtD
Loratadine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.0008	0.00488	CcSEcCtD
Loratadine—Insomnia—Progesterone—uterine cancer	0.000798	0.00487	CcSEcCtD
Loratadine—Paraesthesia—Progesterone—uterine cancer	0.000792	0.00483	CcSEcCtD
Loratadine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000787	0.0048	CcSEcCtD
Loratadine—Viral infection—Epirubicin—uterine cancer	0.000785	0.00479	CcSEcCtD
Loratadine—Somnolence—Progesterone—uterine cancer	0.000785	0.00478	CcSEcCtD
Loratadine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000784	0.00478	CcSEcCtD
Loratadine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000781	0.00476	CcSEcCtD
Loratadine—Dyspepsia—Progesterone—uterine cancer	0.000777	0.00474	CcSEcCtD
Loratadine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000777	0.00474	CcSEcCtD
Loratadine—Alopecia—Dactinomycin—uterine cancer	0.000776	0.00473	CcSEcCtD
Loratadine—Gastrointestinal disorder—Progesterone—uterine cancer	0.000762	0.00465	CcSEcCtD
Loratadine—Fatigue—Progesterone—uterine cancer	0.000761	0.00464	CcSEcCtD
Loratadine—Pain—Progesterone—uterine cancer	0.000755	0.0046	CcSEcCtD
Loratadine—Constipation—Progesterone—uterine cancer	0.000755	0.0046	CcSEcCtD
Loratadine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000747	0.00456	CcSEcCtD
Loratadine—Cardiovascular disorder—Doxorubicin—uterine cancer	0.000747	0.00456	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000729	0.00444	CcSEcCtD
Loratadine—Feeling abnormal—Progesterone—uterine cancer	0.000727	0.00444	CcSEcCtD
Loratadine—Viral infection—Doxorubicin—uterine cancer	0.000727	0.00443	CcSEcCtD
Loratadine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000723	0.00441	CcSEcCtD
Loratadine—Gastrointestinal pain—Progesterone—uterine cancer	0.000722	0.0044	CcSEcCtD
Loratadine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000718	0.00438	CcSEcCtD
Loratadine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000711	0.00434	CcSEcCtD
Loratadine—Ill-defined disorder—Dactinomycin—uterine cancer	0.000709	0.00432	CcSEcCtD
Loratadine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000704	0.00429	CcSEcCtD
Loratadine—Body temperature increased—Progesterone—uterine cancer	0.000698	0.00425	CcSEcCtD
Loratadine—Abdominal pain—Progesterone—uterine cancer	0.000698	0.00425	CcSEcCtD
Loratadine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00069	0.00421	CcSEcCtD
Loratadine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00069	0.0042	CcSEcCtD
Loratadine—Malaise—Dactinomycin—uterine cancer	0.000689	0.0042	CcSEcCtD
Loratadine—Salivary hypersecretion—Epirubicin—uterine cancer	0.000689	0.0042	CcSEcCtD
Loratadine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000684	0.00417	CcSEcCtD
Loratadine—Hepatobiliary disease—Etoposide—uterine cancer	0.000669	0.00408	CcSEcCtD
Loratadine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000659	0.00402	CcSEcCtD
Loratadine—HRH1—myometrium—uterine cancer	0.000659	0.0389	CbGeAlD
Loratadine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000654	0.00399	CcSEcCtD
Loratadine—Myalgia—Dactinomycin—uterine cancer	0.000651	0.00397	CcSEcCtD
Loratadine—Discomfort—Dactinomycin—uterine cancer	0.000643	0.00392	CcSEcCtD
Loratadine—KCNH2—uterine cervix—uterine cancer	0.00064	0.0378	CbGeAlD
Loratadine—Salivary hypersecretion—Doxorubicin—uterine cancer	0.000637	0.00389	CcSEcCtD
Loratadine—Asthenia—Progesterone—uterine cancer	0.000633	0.00386	CcSEcCtD
Loratadine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000632	0.00386	CcSEcCtD
Loratadine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000632	0.00386	CcSEcCtD
Loratadine—Diarrhoea—Progesterone—uterine cancer	0.000604	0.00368	CcSEcCtD
Loratadine—KCNH2—renal system—uterine cancer	0.000598	0.0353	CbGeAlD
Loratadine—Dizziness—Progesterone—uterine cancer	0.000584	0.00356	CcSEcCtD
Loratadine—KCNH2—endometrium—uterine cancer	0.000578	0.0341	CbGeAlD
Loratadine—Immune system disorder—Etoposide—uterine cancer	0.000574	0.0035	CcSEcCtD
Loratadine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000574	0.0035	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000568	0.00347	CcSEcCtD
Loratadine—Alopecia—Etoposide—uterine cancer	0.000562	0.00342	CcSEcCtD
Loratadine—Vomiting—Progesterone—uterine cancer	0.000561	0.00342	CcSEcCtD
Loratadine—Rash—Progesterone—uterine cancer	0.000556	0.00339	CcSEcCtD
Loratadine—Dermatitis—Progesterone—uterine cancer	0.000556	0.00339	CcSEcCtD
Loratadine—Headache—Progesterone—uterine cancer	0.000553	0.00337	CcSEcCtD
Loratadine—Increased appetite—Epirubicin—uterine cancer	0.000548	0.00334	CcSEcCtD
Loratadine—CYP2C8—renal system—uterine cancer	0.000547	0.0323	CbGeAlD
Loratadine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000547	0.00334	CcSEcCtD
Loratadine—Dysgeusia—Etoposide—uterine cancer	0.000542	0.0033	CcSEcCtD
Loratadine—Dermatitis bullous—Epirubicin—uterine cancer	0.000539	0.00329	CcSEcCtD
Loratadine—Fatigue—Dactinomycin—uterine cancer	0.000538	0.00328	CcSEcCtD
Loratadine—Pain—Dactinomycin—uterine cancer	0.000533	0.00325	CcSEcCtD
Loratadine—KCNH2—uterus—uterine cancer	0.000533	0.0315	CbGeAlD
Loratadine—CYP2C8—endometrium—uterine cancer	0.000529	0.0312	CbGeAlD
Loratadine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000529	0.00323	CcSEcCtD
Loratadine—Lethargy—Epirubicin—uterine cancer	0.000525	0.0032	CcSEcCtD
Loratadine—Nausea—Progesterone—uterine cancer	0.000524	0.0032	CcSEcCtD
Loratadine—HRH1—epithelium—uterine cancer	0.000517	0.0305	CbGeAlD
Loratadine—Feeling abnormal—Dactinomycin—uterine cancer	0.000514	0.00313	CcSEcCtD
Loratadine—Ill-defined disorder—Etoposide—uterine cancer	0.000513	0.00313	CcSEcCtD
Loratadine—HRH1—uterine cervix—uterine cancer	0.000513	0.0303	CbGeAlD
Loratadine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00051	0.00311	CcSEcCtD
Loratadine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000508	0.0031	CcSEcCtD
Loratadine—Increased appetite—Doxorubicin—uterine cancer	0.000507	0.00309	CcSEcCtD
Loratadine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000504	0.00308	CcSEcCtD
Loratadine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000504	0.00307	CcSEcCtD
Loratadine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000501	0.00306	CcSEcCtD
Loratadine—Malaise—Etoposide—uterine cancer	0.000499	0.00304	CcSEcCtD
Loratadine—Dermatitis bullous—Doxorubicin—uterine cancer	0.000499	0.00304	CcSEcCtD
Loratadine—HRH1—smooth muscle tissue—uterine cancer	0.000498	0.0294	CbGeAlD
Loratadine—Body temperature increased—Dactinomycin—uterine cancer	0.000493	0.00301	CcSEcCtD
Loratadine—Abdominal pain—Dactinomycin—uterine cancer	0.000493	0.00301	CcSEcCtD
Loratadine—HRH1—decidua—uterine cancer	0.000488	0.0288	CbGeAlD
Loratadine—Loss of consciousness—Etoposide—uterine cancer	0.000486	0.00297	CcSEcCtD
Loratadine—Lethargy—Doxorubicin—uterine cancer	0.000486	0.00297	CcSEcCtD
Loratadine—Cough—Etoposide—uterine cancer	0.000483	0.00294	CcSEcCtD
Loratadine—KCNH2—female reproductive system—uterine cancer	0.000479	0.0283	CbGeAlD
Loratadine—Hypertension—Etoposide—uterine cancer	0.000478	0.00291	CcSEcCtD
Loratadine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000475	0.0029	CcSEcCtD
Loratadine—Chest pain—Etoposide—uterine cancer	0.000471	0.00287	CcSEcCtD
Loratadine—Abdominal pain upper—Epirubicin—uterine cancer	0.00047	0.00287	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000468	0.00285	CcSEcCtD
Loratadine—Discomfort—Etoposide—uterine cancer	0.000465	0.00284	CcSEcCtD
Loratadine—HRH1—endometrium—uterine cancer	0.000464	0.0274	CbGeAlD
Loratadine—Gastritis—Epirubicin—uterine cancer	0.000456	0.00278	CcSEcCtD
Loratadine—CYP2C19—vagina—uterine cancer	0.000454	0.0268	CbGeAlD
Loratadine—Anaphylactic shock—Etoposide—uterine cancer	0.000451	0.00275	CcSEcCtD
Loratadine—HRH1—mammalian vulva—uterine cancer	0.000448	0.0265	CbGeAlD
Loratadine—Asthenia—Dactinomycin—uterine cancer	0.000448	0.00273	CcSEcCtD
Loratadine—Tachycardia—Etoposide—uterine cancer	0.000441	0.00269	CcSEcCtD
Loratadine—Skin disorder—Etoposide—uterine cancer	0.000439	0.00267	CcSEcCtD
Loratadine—CYP2C8—female reproductive system—uterine cancer	0.000438	0.0259	CbGeAlD
Loratadine—KCNH2—female gonad—uterine cancer	0.000436	0.0257	CbGeAlD
Loratadine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000435	0.00265	CcSEcCtD
Loratadine—KCNH2—vagina—uterine cancer	0.000433	0.0256	CbGeAlD
Loratadine—Diarrhoea—Dactinomycin—uterine cancer	0.000427	0.0026	CcSEcCtD
Loratadine—Hypotension—Etoposide—uterine cancer	0.000422	0.00257	CcSEcCtD
Loratadine—Gastritis—Doxorubicin—uterine cancer	0.000422	0.00257	CcSEcCtD
Loratadine—Pollakiuria—Epirubicin—uterine cancer	0.000411	0.00251	CcSEcCtD
Loratadine—Paraesthesia—Etoposide—uterine cancer	0.000405	0.00247	CcSEcCtD
Loratadine—Somnolence—Etoposide—uterine cancer	0.000401	0.00245	CcSEcCtD
Loratadine—Drowsiness—Epirubicin—uterine cancer	0.000397	0.00242	CcSEcCtD
Loratadine—Vomiting—Dactinomycin—uterine cancer	0.000397	0.00242	CcSEcCtD
Loratadine—CYP2C8—vagina—uterine cancer	0.000397	0.0234	CbGeAlD
Loratadine—Rash—Dactinomycin—uterine cancer	0.000393	0.0024	CcSEcCtD
Loratadine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00039	0.00238	CcSEcCtD
Loratadine—CYP2C9—female reproductive system—uterine cancer	0.000389	0.023	CbGeAlD
Loratadine—Fatigue—Etoposide—uterine cancer	0.000389	0.00237	CcSEcCtD
Loratadine—Pain—Etoposide—uterine cancer	0.000386	0.00235	CcSEcCtD
Loratadine—Constipation—Etoposide—uterine cancer	0.000386	0.00235	CcSEcCtD
Loratadine—HRH1—female reproductive system—uterine cancer	0.000384	0.0227	CbGeAlD
Loratadine—Pollakiuria—Doxorubicin—uterine cancer	0.00038	0.00232	CcSEcCtD
Loratadine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000375	0.00229	CcSEcCtD
Loratadine—Epistaxis—Epirubicin—uterine cancer	0.000374	0.00228	CcSEcCtD
Loratadine—Feeling abnormal—Etoposide—uterine cancer	0.000372	0.00227	CcSEcCtD
Loratadine—CYP3A4—renal system—uterine cancer	0.000371	0.0219	CbGeAlD
Loratadine—Nausea—Dactinomycin—uterine cancer	0.000371	0.00226	CcSEcCtD
Loratadine—Gastrointestinal pain—Etoposide—uterine cancer	0.000369	0.00225	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—uterine cancer	0.000367	0.00224	CcSEcCtD
Loratadine—CYP2D6—renal system—uterine cancer	0.000365	0.0215	CbGeAlD
Loratadine—ABCB1—myometrium—uterine cancer	0.000361	0.0213	CbGeAlD
Loratadine—Abdominal pain—Etoposide—uterine cancer	0.000357	0.00218	CcSEcCtD
Loratadine—Body temperature increased—Etoposide—uterine cancer	0.000357	0.00218	CcSEcCtD
Loratadine—Pharyngitis—Epirubicin—uterine cancer	0.000354	0.00216	CcSEcCtD
Loratadine—HRH1—female gonad—uterine cancer	0.000349	0.0206	CbGeAlD
Loratadine—HRH1—vagina—uterine cancer	0.000347	0.0205	CbGeAlD
Loratadine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000347	0.00212	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—uterine cancer	0.000346	0.00211	CcSEcCtD
Loratadine—Tinnitus—Epirubicin—uterine cancer	0.000332	0.00203	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—uterine cancer	0.000327	0.00199	CcSEcCtD
Loratadine—Asthenia—Etoposide—uterine cancer	0.000324	0.00198	CcSEcCtD
Loratadine—Immune system disorder—Epirubicin—uterine cancer	0.000322	0.00196	CcSEcCtD
Loratadine—Arrhythmia—Epirubicin—uterine cancer	0.000318	0.00194	CcSEcCtD
Loratadine—Alopecia—Epirubicin—uterine cancer	0.000315	0.00192	CcSEcCtD
Loratadine—Diarrhoea—Etoposide—uterine cancer	0.000309	0.00188	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—uterine cancer	0.000307	0.00187	CcSEcCtD
Loratadine—Tension—Epirubicin—uterine cancer	0.000304	0.00186	CcSEcCtD
Loratadine—Dysgeusia—Epirubicin—uterine cancer	0.000304	0.00185	CcSEcCtD
Loratadine—Nervousness—Epirubicin—uterine cancer	0.000301	0.00184	CcSEcCtD
Loratadine—Dizziness—Etoposide—uterine cancer	0.000299	0.00182	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—uterine cancer	0.000298	0.00182	CcSEcCtD
Loratadine—CYP3A4—female reproductive system—uterine cancer	0.000297	0.0175	CbGeAlD
Loratadine—Arrhythmia—Doxorubicin—uterine cancer	0.000294	0.0018	CcSEcCtD
Loratadine—CYP2D6—female reproductive system—uterine cancer	0.000292	0.0172	CbGeAlD
Loratadine—Alopecia—Doxorubicin—uterine cancer	0.000291	0.00178	CcSEcCtD
Loratadine—Ill-defined disorder—Epirubicin—uterine cancer	0.000288	0.00175	CcSEcCtD
Loratadine—Vomiting—Etoposide—uterine cancer	0.000287	0.00175	CcSEcCtD
Loratadine—Agitation—Epirubicin—uterine cancer	0.000285	0.00174	CcSEcCtD
Loratadine—Rash—Etoposide—uterine cancer	0.000285	0.00174	CcSEcCtD
Loratadine—Dermatitis—Etoposide—uterine cancer	0.000284	0.00173	CcSEcCtD
Loratadine—ABCB1—epithelium—uterine cancer	0.000283	0.0167	CbGeAlD
Loratadine—Headache—Etoposide—uterine cancer	0.000283	0.00172	CcSEcCtD
Loratadine—Tension—Doxorubicin—uterine cancer	0.000282	0.00172	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—uterine cancer	0.000281	0.00171	CcSEcCtD
Loratadine—ABCB1—uterine cervix—uterine cancer	0.000281	0.0166	CbGeAlD
Loratadine—KCNH2—lymph node—uterine cancer	0.00028	0.0165	CbGeAlD
Loratadine—Malaise—Epirubicin—uterine cancer	0.00028	0.00171	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—uterine cancer	0.000279	0.0017	CcSEcCtD
Loratadine—Syncope—Epirubicin—uterine cancer	0.000278	0.0017	CcSEcCtD
Loratadine—Palpitations—Epirubicin—uterine cancer	0.000274	0.00167	CcSEcCtD
Loratadine—Loss of consciousness—Epirubicin—uterine cancer	0.000273	0.00166	CcSEcCtD
Loratadine—Cough—Epirubicin—uterine cancer	0.000271	0.00165	CcSEcCtD
Loratadine—Nausea—Etoposide—uterine cancer	0.000268	0.00164	CcSEcCtD
Loratadine—Hypertension—Epirubicin—uterine cancer	0.000268	0.00163	CcSEcCtD
Loratadine—ABCB1—decidua—uterine cancer	0.000267	0.0158	CbGeAlD
Loratadine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000266	0.00162	CcSEcCtD
Loratadine—CYP2D6—female gonad—uterine cancer	0.000266	0.0157	CbGeAlD
Loratadine—Chest pain—Epirubicin—uterine cancer	0.000264	0.00161	CcSEcCtD
Loratadine—Myalgia—Epirubicin—uterine cancer	0.000264	0.00161	CcSEcCtD
Loratadine—Agitation—Doxorubicin—uterine cancer	0.000264	0.00161	CcSEcCtD
Loratadine—ABCB1—renal system—uterine cancer	0.000262	0.0155	CbGeAlD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000262	0.0016	CcSEcCtD
Loratadine—Discomfort—Epirubicin—uterine cancer	0.000261	0.00159	CcSEcCtD
Loratadine—Malaise—Doxorubicin—uterine cancer	0.000259	0.00158	CcSEcCtD
Loratadine—Dry mouth—Epirubicin—uterine cancer	0.000258	0.00157	CcSEcCtD
Loratadine—Syncope—Doxorubicin—uterine cancer	0.000257	0.00157	CcSEcCtD
Loratadine—ABCB1—endometrium—uterine cancer	0.000254	0.015	CbGeAlD
Loratadine—Palpitations—Doxorubicin—uterine cancer	0.000254	0.00155	CcSEcCtD
Loratadine—Anaphylactic shock—Epirubicin—uterine cancer	0.000253	0.00154	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—uterine cancer	0.000252	0.00154	CcSEcCtD
Loratadine—Cough—Doxorubicin—uterine cancer	0.00025	0.00153	CcSEcCtD
Loratadine—Shock—Epirubicin—uterine cancer	0.000249	0.00152	CcSEcCtD
Loratadine—Nervous system disorder—Epirubicin—uterine cancer	0.000248	0.00151	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—uterine cancer	0.000248	0.00151	CcSEcCtD
Loratadine—Tachycardia—Epirubicin—uterine cancer	0.000247	0.00151	CcSEcCtD
Loratadine—Skin disorder—Epirubicin—uterine cancer	0.000246	0.0015	CcSEcCtD
Loratadine—ABCB1—mammalian vulva—uterine cancer	0.000245	0.0145	CbGeAlD
Loratadine—Chest pain—Doxorubicin—uterine cancer	0.000244	0.00149	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—uterine cancer	0.000244	0.00149	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000243	0.00148	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—uterine cancer	0.000241	0.00147	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—uterine cancer	0.000239	0.00146	CcSEcCtD
Loratadine—Hypotension—Epirubicin—uterine cancer	0.000236	0.00144	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000234	0.00143	CcSEcCtD
Loratadine—ABCB1—uterus—uterine cancer	0.000234	0.0138	CbGeAlD
Loratadine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000231	0.00141	CcSEcCtD
Loratadine—Shock—Doxorubicin—uterine cancer	0.00023	0.0014	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—uterine cancer	0.00023	0.0014	CcSEcCtD
Loratadine—Insomnia—Epirubicin—uterine cancer	0.000229	0.0014	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—uterine cancer	0.000229	0.00139	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—uterine cancer	0.000227	0.00139	CcSEcCtD
Loratadine—Paraesthesia—Epirubicin—uterine cancer	0.000227	0.00139	CcSEcCtD
Loratadine—Somnolence—Epirubicin—uterine cancer	0.000225	0.00137	CcSEcCtD
Loratadine—HRH1—lymph node—uterine cancer	0.000225	0.0133	CbGeAlD
Loratadine—Dyspepsia—Epirubicin—uterine cancer	0.000223	0.00136	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—uterine cancer	0.000219	0.00133	CcSEcCtD
Loratadine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000218	0.00133	CcSEcCtD
Loratadine—Fatigue—Epirubicin—uterine cancer	0.000218	0.00133	CcSEcCtD
Loratadine—Pain—Epirubicin—uterine cancer	0.000216	0.00132	CcSEcCtD
Loratadine—Constipation—Epirubicin—uterine cancer	0.000216	0.00132	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000213	0.0013	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—uterine cancer	0.000212	0.00129	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—uterine cancer	0.00021	0.00128	CcSEcCtD
Loratadine—ABCB1—female reproductive system—uterine cancer	0.00021	0.0124	CbGeAlD
Loratadine—Feeling abnormal—Epirubicin—uterine cancer	0.000209	0.00127	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—uterine cancer	0.000208	0.00127	CcSEcCtD
Loratadine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000207	0.00126	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—uterine cancer	0.000206	0.00126	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000202	0.00123	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—uterine cancer	0.000202	0.00123	CcSEcCtD
Loratadine—Constipation—Doxorubicin—uterine cancer	0.0002	0.00122	CcSEcCtD
Loratadine—Pain—Doxorubicin—uterine cancer	0.0002	0.00122	CcSEcCtD
Loratadine—Abdominal pain—Epirubicin—uterine cancer	0.0002	0.00122	CcSEcCtD
Loratadine—Body temperature increased—Epirubicin—uterine cancer	0.0002	0.00122	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—uterine cancer	0.000193	0.00118	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000191	0.00117	CcSEcCtD
Loratadine—ABCB1—female gonad—uterine cancer	0.000191	0.0113	CbGeAlD
Loratadine—ABCB1—vagina—uterine cancer	0.00019	0.0112	CbGeAlD
Loratadine—Body temperature increased—Doxorubicin—uterine cancer	0.000185	0.00113	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—uterine cancer	0.000185	0.00113	CcSEcCtD
Loratadine—Asthenia—Epirubicin—uterine cancer	0.000182	0.00111	CcSEcCtD
Loratadine—Diarrhoea—Epirubicin—uterine cancer	0.000173	0.00106	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—uterine cancer	0.000168	0.00102	CcSEcCtD
Loratadine—Dizziness—Epirubicin—uterine cancer	0.000167	0.00102	CcSEcCtD
Loratadine—Vomiting—Epirubicin—uterine cancer	0.000161	0.000981	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—uterine cancer	0.00016	0.000977	CcSEcCtD
Loratadine—Rash—Epirubicin—uterine cancer	0.00016	0.000973	CcSEcCtD
Loratadine—Dermatitis—Epirubicin—uterine cancer	0.000159	0.000972	CcSEcCtD
Loratadine—Headache—Epirubicin—uterine cancer	0.000159	0.000967	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—uterine cancer	0.000155	0.000944	CcSEcCtD
Loratadine—Nausea—Epirubicin—uterine cancer	0.00015	0.000917	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—uterine cancer	0.000149	0.000908	CcSEcCtD
Loratadine—Rash—Doxorubicin—uterine cancer	0.000148	0.0009	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—uterine cancer	0.000148	0.0009	CcSEcCtD
Loratadine—Headache—Doxorubicin—uterine cancer	0.000147	0.000895	CcSEcCtD
Loratadine—Nausea—Doxorubicin—uterine cancer	0.000139	0.000848	CcSEcCtD
Loratadine—ABCB1—lymph node—uterine cancer	0.000123	0.00726	CbGeAlD
